Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Supreme Rejuvenation Gets FDA Warning Letter Over Exosomes Claims - Happi
Regulations

Supreme Rejuvenation Gets FDA Warning Letter Over Exosomes Claims

Products make unapproved drug claims, according to Agency.

Supreme Rejuvenation, LLC, Houston, TX, received a Warning Letter from the US Food and Drug Administration. The FDA reviewed the company’s websites, including www.supremerejuvenation.com and www.instagram.com/supremeexosomes. The site indicates that Supreme Rejuvenation sells “100 Billion Exosomes: Human Umbilical Cord Mesenchymal Stem Cell Derived Exosomes,” “15 ml 100 Billion Exosomes: Stem Cell Exosome Gel,” and “30 ml 200 Billion Exosomes: Stem Cell Exosome Gel” for allogeneic use.”

FDA said the products are unapproved new drugs in violation of section 505(a) of the Federal Food, Drug, and Cosmetic Act (FD&C Act), 21 U.S.C. § 355(a). Products are also unlicensed biological products in violation of section 351(a)(1) of the Public Health Service Act (PHS Act), 42 U.S.C. § 262(a)(1). 

Based on information reviewed by FDA, including Supreme Rejuvenation websites, www.supremerejuvenation.com and www.instagram.com/supremeexosomes, the products are intended for use in the diagnosis, cure, mitigation, treatment or prevention of disease or conditions in humans and/or are intended to affect the structure or function of the body.

Add us as a preferred source on Google

Get the latest Happi news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Happi Newsletters